Provided by Tiger Trade Technology Pte. Ltd.

Cellectar Biosciences

2.70
-0.2000-6.90%
Post-market: 2.700.00000.00%19:12 EDT
Volume:31.45K
Turnover:88.11K
Market Cap:11.45M
PE:-0.32
High:2.87
Open:2.87
Low:2.70
Close:2.90
52wk High:20.59
52wk Low:2.45
Shares:4.24M
Float Shares:4.06M
Volume Ratio:1.15
T/O Rate:0.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.3544
EPS(LYR):-8.3544
ROE:-170.27%
ROA:-71.01%
PB:1.43
PE(LYR):-0.32

Loading ...

Cellectar Biosciences Raised to Buy From Hold by Maxim Group

Dow Jones
·
Mar 10

Cellectar Biosciences Inc : Maxim Group Raises to Buy From Hold

THOMSON REUTERS
·
Mar 10

U.S. RESEARCH ROUNDUP-Adobe, Caseys General Stores, FedEx

Reuters
·
Mar 10

Cellectar Biosciences Charts Risky Path to Approvals

TIPRANKS
·
Mar 10

Cellectar Biosciences Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 04

Cellectar Biosciences Q4 EPS $(0.53) Beats $(2.29) Estimate

Benzinga
·
Mar 04

Cellectar Biosciences reports FY25 EPS ($8.35) vs ($41.89) last year

TIPRANKS
·
Mar 04

Cellectar BioSciences FY 2025 net loss USD 21.8 million

Reuters
·
Mar 04

Press Release: Cellectar Biosciences Reports Financial Results for Year Ended 2025 and Provides Corporate Updates

Dow Jones
·
Mar 04

Cellectar Biosciences Inc expected to post a loss of $2.02 a share - Earnings Preview

Reuters
·
Mar 02

Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Wednesday, March 4, 2026

GlobeNewswire
·
Feb 25

Cellectar Biosciences Secures New Patents to Strengthen Global Cancer Drug Portfolio

Reuters
·
Feb 17

Cellectar Biosciences Expands Global Intellectual Property Estate

GlobeNewswire
·
Feb 17

Cellectar BioSciences Showcases Pipeline Advancements and Radiotherapeutic Platform in New Corporate Presentation

Reuters
·
Jan 13

Cellectar Biosciences To Highlight Strategic Initiatives For 2026

Reuters
·
Jan 09

Cellectar Biosciences to highlight company’s 2026 strategic initiatives

TIPRANKS
·
Jan 09

Cellectar Biosciences to Highlight Strategic Initiatives for 2026 at Upcoming Biotech Showcase during 44th Annual JP Morgan Healthcare Conference

GlobeNewswire
·
Jan 09

Director John Neis Reports Disposal of Cellectar BioSciences Inc. Common Shares

Reuters
·
Dec 17, 2025

BRIEF-Cellectar Biosciences Announces Strategic Supply Agreement With Ionetix

Reuters
·
Dec 16, 2025

Cellectar BioSciences Partners with Ionetix for Alpha-Emitting Isotope Supply

Reuters
·
Dec 16, 2025